Increased Cerebrospinal Fluid Adenosine 5'-Triphosphate Levels in Patients with Guillain-Barré Syndrome and Chronic Inflammatory Demyelinating Polyneuropathy.
Takamasa NukuiHideki NiimiTomohiro HayashiNobuhiro DouguMamoru YamamotoRyoko ShibuyaNoriyuki MatsudaRyo TanakaHiroaki HirosawaRisako FurutaTaichi MitsuiHiroki MaesakaSyuhei TakasawaIsao KitajimaYuji NakatsujiPublished in: Neurology research international (2024)
CSF ATP levels were increased in patients with GBS and CIDP. In particular, CSF ATP levels tended to decrease following treatment in patients with CIDP. CSF ATP levels may be useful biomarkers for the diagnosis or monitoring of therapeutic effects in patients with GBS and CIDP.